[SGMO] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
24-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- 21.37%
YoY- 7.65%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 26,460 29,378 28,231 27,986 28,563 27,872 26,280 0.45%
PBT -53,125 -43,091 -43,919 -37,563 -47,602 -47,150 -45,677 10.58%
Tax 30 82 58 -67 86 24 262 -76.38%
NP -53,155 -43,173 -43,977 -37,496 -47,688 -47,169 -45,933 10.21%
Tax Rate - - - - - - - -
Total Cost 79,615 72,551 72,208 65,482 76,251 75,041 72,213 6.71%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -200.89 -146.96 -155.78 -133.98 -166.96 -169.23 -174.78 9.71%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.34 -0.29 -0.30 -0.26 -0.33 -0.33 -0.32 4.12%
EPS Diluted -0.34 -0.29 -0.30 -0.26 -0.33 -0.33 -0.32 4.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.